The Pharmacodynamics of Meropenem in Patient With Ventilator-associated Pneumonia

PHASE4CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
Ventilator-Associated Pneumonia
Interventions
DRUG

Meropenem

1 g in 100 ml of normal saline solution and administered via bolus injection Blood samples (approximately 5 ml)will be obtained by direct venepuncture at the following time: before (time zero) and 10 and 30 min and 1, 1.5, 2, 2.5, 3.5, 4, 4.5, 5, 6, and 8 hh after 3rd dose of meropenem

DRUG

Meropenem

"1 g in 100 ml of normal saline solution and administered via an infusion pump at a constant flow rate over 3 h every 8 h.~Blood samples (approximately 5 ml)will be obtained by direct venepuncture at the following time: before (time zero) and 10 and 30 min and~1, 1.5, 2, 2.5, 3.5, 4, 4.5, 5, 6, and 8 h after the 3rd dose of meropenem."

DRUG

Meropenem

"2 g in 100 ml of normal saline solution and administered via an infusion pump at a constant flow rate over 3 h every 8 h.~Blood samples (approximately 5 ml)will be obtained by direct venepuncture at the following time: before (time zero) and 10 and 30 min and 1, 1.5, 2, 2.5, 3.5, 4, 4.5, 5, 6, and 8 h after the 3rd dose of meropenem."

Trial Locations (1)

90110

Prince of Songkla University, Hat Yai

All Listed Sponsors
collaborator

Prince of Songkla University

OTHER

lead

Sutep Jaruratanasirikul

OTHER

NCT02615041 - The Pharmacodynamics of Meropenem in Patient With Ventilator-associated Pneumonia | Biotech Hunter | Biotech Hunter